| +0.01 / +0.40%|
SEQUENOM, Inc. is a life sciences company providing innovative genomic and genetic analysis solutions for the clinical research and molecular diagnostic markets. The company operates its business under two segments: Sequenom Laboratories and Sequenom Bioscience. The Sequenom Laboratories segment runs through its subsidiary, Sequenom Center for Molecular Medicine, LLC, which performs molecular diagnostic testing services utilizing its laboratory-developed tests which are currently focused on noninvasive prenatal and women's health related diagnostics and ophthalmology-related diagnostics and plans to develop or acquire additional diagnostic tests in those and other fields including autoimmunity, neurology and oncology. The Sequenom Bioscience segment which provides research use technologies and tools that translate the results of genomic science into solutions for biomedical research, translational research, oncology, agricultural genomics, clinical diagnostics, molecular medicine applications, and other areas of research, including agricultural and livestock. SEQUENOM was founded by Hubert Koester and Charles R. Cantor in 1994 and is headquartered in San Diego, CA.
|Harry F. Hixson||Chairman & Chief Executive Officer|
|William J. Welch||President & Chief Operating Officer|
|Paul V. Maier||Chief Financial Officer|
|Charles R. Cantor||Chief Scientific Officer|
|Dirk van den Boom||CTO, Executive VP-Research & Development|